Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era

A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703

(2020) Zachariah DeFilipp et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

(2019) Javier Bolaños-Meade et al.   Lancet Haematology

Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study

(2019) Yves Soltermann et al.   ANNALS OF HEMATOLOGY

Characterization of viral infections following antithymocyte globulin-based conditioning in adults undergoing allogeneic hematopoietic stem cell transplantation

(2019) Bradley Figgins et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

(2018) Annalisa Ruggeri et al.   Journal of Hematology & Oncology

Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia

(2017) Vishal Dhere et al.   LEUKEMIA & LYMPHOMA

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease

(2016) Nicolaus Kröger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rabbit Anti–T Cell Globulin in Allogeneic Hematopoietic Cell Transplantation

(2015) Jan Storek et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Post-Transplant High-Dose Cyclophosphamide for the Prevention of Graft-versus-Host Disease

(2015) Ahmad Samer Al-Homsi et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation

(2015) Alessandra Roberto et al.   BLOOD

HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide

(2015) E J Fuchs   BONE MARROW TRANSPLANTATION

Late Cardiovascular Complications after Hematopoietic Cell Transplantation

(2014) Eric J. Chow et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

(2014) Christopher G. Kanakry et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation

(2013) Eric J. Chow et al.   ANNALS OF INTERNAL MEDICINE

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

(2010) L. Luznik et al.   BLOOD

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Low Left Ventricular Ejection Fraction

(2009) Muzaffar H. Qazilbash et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Cardiovascular disease after hematopoietic cell transplantation - lessons learned

(2008) S. H. Armenian et al.   HAEMATOLOGICA